Acute fluoxetine overdose: a report of 234 cases
- PMID: 1586402
- DOI: 10.1016/0735-6757(92)90041-u
Acute fluoxetine overdose: a report of 234 cases
Abstract
Limited toxicity information is available in the medical literature on the antidepressant fluoxetine (Prozac, Dista Products Co, Indianapolis, IN). The goal of this prospective multicenter study was to develop a toxicity profile of initial signs and symptoms observed in an acute fluoxetine overdose. A prospective study was made of patients reported to one of four American Association of Poison Control Centers' regional poison control centers after ingesting an acute overdose of fluoxetine. A standard data collection form was used on all patients ingesting fluoxetine. Information obtained included age, current medications, dose, coingested drugs, presenting symptoms, vital signs, electrocardiogram abnormalities, outcome, and fluoxetine levels. The authors collected 272 cases; 234 cases met the criteria of the study. Fluoxetine was ingested alone in 87 cases and with ethanol or other drugs in the remaining 147 cases. Of the 87 cases where fluoxetine was ingested alone, 67 patients were adults and 20 were children. Symptoms that were seen in the adult group included: tachycardia (15/67), drowsiness (14/67), tremor (five/67), vomiting (four/67), or nausea (four/67). Thirty patients did not develop symptoms. Twelve of the adult overdose patients had total fluoxetine levels ranging from 232 to 1390 ng/mL. The authors conclude that symptoms that develop after an acute overdose of fluoxetine appear minor and of short duration. Aggressive supportive care is the only intervention necessary.
Similar articles
-
The effects of fluoxetine in the overdose patient.J Toxicol Clin Toxicol. 1990;28(3):331-40. doi: 10.3109/15563659008994434. J Toxicol Clin Toxicol. 1990. PMID: 2231832 Clinical Trial.
-
Benign course in a child with a massive fluoxetine overdose.J Fam Pract. 1995 Sep;41(3):289-91. J Fam Pract. 1995. PMID: 7650509 Review.
-
Sertraline overdose.Acad Emerg Med. 1996 Feb;3(2):132-6. doi: 10.1111/j.1553-2712.1996.tb03400.x. Acad Emerg Med. 1996. PMID: 8808373
-
Fluoxetine exposures: are they safe for children?Am J Emerg Med. 2004 May;22(3):211-3. doi: 10.1016/j.ajem.2004.02.013. Am J Emerg Med. 2004. PMID: 15138960
-
What can clinicians learn from therapeutic studies about the treatment of acute oral methotrexate poisoning?Clin Toxicol (Phila). 2017 Feb;55(2):88-96. doi: 10.1080/15563650.2016.1271126. Clin Toxicol (Phila). 2017. PMID: 28084171 Review.
Cited by
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2018 Jan 15;48(1):64-153. Psychopharmacol Bull. 2018. PMID: 29382960 Free PMC article. Review. No abstract available.
-
Antidepressant toxicity and the need for identification and concentration monitoring in overdose.Clin Pharmacokinet. 1995 Sep;29(3):154-71. doi: 10.2165/00003088-199529030-00003. Clin Pharmacokinet. 1995. PMID: 8521678 Review.
-
Serum fluoxetine and norfluoxetine levels support the safety of fluoxetine in overdose.Ann Gen Psychiatry. 2016 Nov 9;15:30. doi: 10.1186/s12991-016-0117-z. eCollection 2016. Ann Gen Psychiatry. 2016. PMID: 27843482 Free PMC article.
-
Rapid Ascending Sensorimotor Paralysis, Hearing Loss, and Fatal Arrhythmia in a Multimorbid Patient due to an Accidental Overdose of Fluoxetine.Case Rep Neurol Med. 2017;2017:5415243. doi: 10.1155/2017/5415243. Epub 2017 Oct 16. Case Rep Neurol Med. 2017. PMID: 29123931 Free PMC article.
-
Acute medical costs of fluoxetine versus tricyclic antidepressants. A prospective multicentre study of antidepressant drug overdoses.Pharmacoeconomics. 1997 Jan;11(1):48-55. doi: 10.2165/00019053-199711010-00006. Pharmacoeconomics. 1997. PMID: 10165526 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous